Michael Y.T. Chow

819 total citations
22 papers, 634 citations indexed

About

Michael Y.T. Chow is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Michael Y.T. Chow has authored 22 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Pharmaceutical Science. Recurrent topics in Michael Y.T. Chow's work include Inhalation and Respiratory Drug Delivery (17 papers), Bacteriophages and microbial interactions (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Michael Y.T. Chow is often cited by papers focused on Inhalation and Respiratory Drug Delivery (17 papers), Bacteriophages and microbial interactions (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Michael Y.T. Chow collaborates with scholars based in Australia, Hong Kong and United Kingdom. Michael Y.T. Chow's co-authors include Hak‐Kim Chan, Jenny K.W. Lam, Philip Chi Lip Kwok, Rachel Yoon Kyung Chang, Wanling Liang, Shing Fung Chow, Donghao Chen, Dipesh Khanal, Yingshan Qiu and Qiuying Liao and has published in prestigious journals such as Advanced Drug Delivery Reviews, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael Y.T. Chow

21 papers receiving 617 citations

Peers

Michael Y.T. Chow
Heidi H. Yu Australia
Jim Blanchard United States
Wouter F. Tonnis Netherlands
Sanil D. Singh South Africa
Heidi H. Yu Australia
Michael Y.T. Chow
Citations per year, relative to Michael Y.T. Chow Michael Y.T. Chow (= 1×) peers Heidi H. Yu

Countries citing papers authored by Michael Y.T. Chow

Since Specialization
Citations

This map shows the geographic impact of Michael Y.T. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Y.T. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Y.T. Chow more than expected).

Fields of papers citing papers by Michael Y.T. Chow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Y.T. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Y.T. Chow. The network helps show where Michael Y.T. Chow may publish in the future.

Co-authorship network of co-authors of Michael Y.T. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Y.T. Chow. A scholar is included among the top collaborators of Michael Y.T. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Y.T. Chow. Michael Y.T. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Rachel Yoon Kyung, Chengxi Liu, Yuncheng Wang, et al.. (2024). Using X-ray velocimetry to measure lung function and assess the efficacy of a pseudomonas aeruginosa bacteriophage therapy for cystic fibrosis. Scientific Reports. 14(1). 29727–29727. 2 indexed citations
2.
Chow, Michael Y.T., et al.. (2023). Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis. Pharmaceutical Research. 40(5). 1073–1086. 10 indexed citations
3.
Chow, Michael Y.T., et al.. (2023). Delivery technology of inhaled therapy for asthma and COPD. Advances in pharmacology. 98. 273–311. 3 indexed citations
4.
Chow, Michael Y.T., et al.. (2022). Inhalable neutralizing antibodies – promising approach to combating respiratory viral infections. Trends in Pharmacological Sciences. 44(2). 85–97. 18 indexed citations
5.
Chang, Rachel Yoon Kyung, Michael Y.T. Chow, Yuncheng Wang, et al.. (2022). The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice. Clinical Microbiology and Infection. 28(7). 983–989. 32 indexed citations
6.
Chang, Rachel Yoon Kyung, et al.. (2022). A dual action of D-amino acids on anti-biofilm activity and moisture-protection of inhalable ciprofloxacin powders. European Journal of Pharmaceutics and Biopharmaceutics. 173. 132–140. 13 indexed citations
7.
Qiu, Yingshan, et al.. (2021). Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy. Pharmaceutics. 13(12). 2044–2044. 10 indexed citations
8.
Chow, Michael Y.T., et al.. (2021). Modeling of a spray drying method to produce ciprofloxacin nanocrystals inside the liposomes utilizing a response surface methodology: Box-Behnken experimental design. International Journal of Pharmaceutics. 597. 120277–120277. 41 indexed citations
9.
Chang, Rachel Yoon Kyung, Michael Y.T. Chow, Dipesh Khanal, Donghao Chen, & Hak‐Kim Chan. (2021). Dry powder pharmaceutical biologics for inhalation therapy. Advanced Drug Delivery Reviews. 172. 64–79. 83 indexed citations
10.
Chow, Michael Y.T., et al.. (2021). In vitro-in vivo correlation of cascade impactor data for orally inhaled pharmaceutical aerosols. Advanced Drug Delivery Reviews. 177. 113952–113952. 16 indexed citations
11.
Chow, Michael Y.T., Rachel Yoon Kyung Chang, Mengyu Li, et al.. (2020). Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice. Antimicrobial Agents and Chemotherapy. 65(1). 41 indexed citations
12.
Chow, Michael Y.T., Philip Chi Lip Kwok, Runyu Yang, & Hak‐Kim Chan. (2020). Predicting the composition and size distribution of dry particles for aerosols and sprays of suspension: A Monte Carlo approach. International Journal of Pharmaceutics. 582. 119311–119311. 10 indexed citations
13.
Chang, Rachel Yoon Kyung, et al.. (2020). Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34(1). 20–31. 17 indexed citations
14.
Qiu, Yingshan, Qiuying Liao, Michael Y.T. Chow, & Jenny K.W. Lam. (2020). Intratracheal Administration of Dry Powder Formulation in Mice. Journal of Visualized Experiments. 16 indexed citations
15.
Lam, Jenny K.W., et al.. (2020). Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic. Advanced Drug Delivery Reviews. 160. 234–243. 55 indexed citations
16.
Lin, Yu, Diana H. Quan, Rachel Yoon Kyung Chang, et al.. (2020). Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model. European Journal of Pharmaceutics and Biopharmaceutics. 158. 166–171. 54 indexed citations
17.
Liao, Qiuying, Michael Y.T. Chow, Shing Fung Chow, et al.. (2019). Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition. International Journal of Pharmaceutics. 560. 144–154. 52 indexed citations
18.
Liang, Wanling, Michael Y.T. Chow, Shing Fung Chow, et al.. (2018). Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation. International Journal of Pharmaceutics. 552(1-2). 67–75. 46 indexed citations
19.
Liang, Wanling, et al.. (2017). Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery. Asian Journal of Pharmaceutical Sciences. 13(2). 163–172. 55 indexed citations
20.
Liang, Wanling, Philip Chi Lip Kwok, Michael Y.T. Chow, et al.. (2013). Formulation of pH responsive peptides as inhalable dry powders for pulmonary delivery of nucleic acids. European Journal of Pharmaceutics and Biopharmaceutics. 86(1). 64–73. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026